Anixa Biosciences
ANIX
#9392
Rank
โ‚น12.13 B
Marketcap
โ‚น356.76
Share price
-1.47%
Change (1 day)
22.12%
Change (1 year)

Revenue for Anixa Biosciences (ANIX)

Revenue in 2026 (TTM): N/A

In 2025 the company made a revenue of N/A a decrease over the revenue in the year 2024 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Anixa Biosciences from 1996 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) N/A
2025 N/A
2024 N/A-100%
2023 โ‚น17.48 M
2022 N/A
2021 N/A-100%
2020 โ‚น37.51 M110.45%
2019 โ‚น17.82 M-77.08%
2018 โ‚น77.78 M236.08%
2017 โ‚น23.14 M13.54%
2016 โ‚น20.38 M155.64%
2015 โ‚น7.97 M-99.02%
2014 โ‚น0.81 B3296.12%
2013 โ‚น23.89 M-12.36%
2012 โ‚น27.26 M-64.1%
2011 โ‚น75.93 M139.09%
2010 โ‚น31.75 M-5.01%
2009 โ‚น33.43 M-70.84%
2008 โ‚น0.11 B615.37%
2007 โ‚น16.02 M-18.51%
2006 โ‚น19.66 M3.41%
2005 โ‚น19.01 M-34.27%
2004 โ‚น28.93 M231.17%
2003 โ‚น8.73 M-95.45%
2002 โ‚น0.19 B42.53%
2001 โ‚น0.13 B109.98%
2000 โ‚น64.1 M291.34%
1999 โ‚น16.38 M-3.69%
1998 โ‚น17 M44.26%
1997 โ‚น11.78 M9.32%
1996 โ‚น10.78 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA